Skip directly to content

Mark Harrington's keynote speech at the Critical Path to TB Drug Regimens meeting

March 20, 2017 – Mark Harrington, TAG's executive director, included in his keynote speech at the Critical Path to TB Drug Regimens meeting the importance of public and private sector funding for research, of thoughtful regulatory strategies, and of rapid uptake of new, evidence-based tools.